Literature DB >> 8314440

Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population.

E J de Koning1, N L Bodkin, B C Hansen, A Clark.   

Abstract

Diabetes mellitus in Macaca mulatta rhesus monkeys is preceded by phases of obesity and hyperinsulinaemia and is similar to Type 2 (non-insulin-dependent) diabetes mellitus in man. To relate the progression of the disease to quantitative changes in islet morphology, post-mortem pancreatic tissue from 26 monkeys was examined. Four groups of animals were studied: group I--young, lean and normal (n = 3); group II--older (> 10 years), lean and obese, normoglycaemic (n = 9); group III--normoglycaemic and hyperinsulinaemic (n = 6); group IV--diabetic (n = 8). Areas of islet amyloid, beta cells and islets were measured on stained histological sections. Islet size was larger in animals from groups III (p < 0.01) and IV (p < 0.0001) compared to groups I and II. The mean beta-cell area per islet in micron 2 was increased in group III (p < 0.05) and reduced in group IV (p < 0.001) compared to groups I and II. Mean beta-cell area per islet correlated with fasting plasma insulin (r = 0.76, p < 0.001) suggesting that hyper- and hypoinsulinaemia are related to the beta-cell population. Amyloid was absent in group I but small deposits were present in three of nine (group II) and in four of six (group III) animals, occupying between 0.03-45% of the islet space. Amyloid was present in eight of eight diabetic animals (group IV) occupying between 37-81% of the islet area. Every islet was affected in seven of eight diabetic monkeys. There was no correlation of degree of amyloidosis with age, body weight, body fat proportion or fasting insulin. Islet amyloid appears to precede the development of overt diabetes in Macaca mulatta and is likely to be a factor in the destruction of islet cells and onset of hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314440     DOI: 10.1007/bf00402271

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion.

Authors:  S Bonner-Weir; D Deery; J L Leahy; G C Weir
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

2.  Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes.

Authors:  K Jordan; M P Murtaugh; T D O'Brien; P Westermark; C Betsholtz; K H Johnson
Journal:  Biochem Biophys Res Commun       Date:  1990-06-15       Impact factor: 3.575

3.  Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells.

Authors:  K H Johnson; T D O'Brien; K Jordan; P Westermark
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  Sequences of islet amyloid polypeptide precursors of an Old World monkey, the pig-tailed macaque (Macaca nemestrina), and the dog (Canis familiaris).

Authors:  S Ohagi; M Nishi; G I Bell; J W Ensinck; D F Steiner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

5.  Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons.

Authors:  D K McCulloch; D J Koerker; S E Kahn; S Bonner-Weir; J P Palmer
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

6.  Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects.

Authors:  A Clark; C A Edwards; L R Ostle; R Sutton; J B Rothbard; J F Morris; R C Turner
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

Review 7.  Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.

Authors:  K H Johnson; T D O'Brien; C Betsholtz; P Westermark
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

8.  Longitudinal studies on the development of diabetes in individual Macaca nigra.

Authors:  C F Howard
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

9.  Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects.

Authors:  K Saito; N Yaginuma; T Takahashi
Journal:  Tohoku J Exp Med       Date:  1979-11       Impact factor: 1.848

10.  Cellular composition of the human diabetic pancreas.

Authors:  J Rahier; R M Goebbels; J C Henquin
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

View more
  44 in total

1.  Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model.

Authors:  Chengyang Liu; Brigitte Koeberlein; Michael D Feldman; Rebecca Mueller; Zhonglin Wang; Yanjing Li; Kristin Lane; Clifford C Hoyt; John E Tomaszewski; Ali Naji; Michael R Rickels
Journal:  Endocrinology       Date:  2012-02-21       Impact factor: 4.736

Review 2.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

Authors:  Esther S O'Sullivan; Arturo Vegas; Daniel G Anderson; Gordon C Weir
Journal:  Endocr Rev       Date:  2011-09-27       Impact factor: 19.871

Review 3.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 4.  The value of extended pedigrees for next-generation analysis of complex disease in the rhesus macaque.

Authors:  Amanda Vinson; Kamm Prongay; Betsy Ferguson
Journal:  ILAR J       Date:  2013

Review 5.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

Review 6.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

Review 7.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

8.  Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia.

Authors:  J W Höppener; J S Verbeek; E J de Koning; C Oosterwijk; K L van Hulst; H J Visser-Vernooy; F M Hofhuis; S van Gaalen; M J Berends; W H Hackeng
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

Review 9.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

Review 10.  Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure.

Authors:  Arne Andersson; Sara Bohman; L A Håkan Borg; Johan F Paulsson; Sebastian W Schultz; Gunilla T Westermark; Per Westermark
Journal:  Exp Diabetes Res       Date:  2009-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.